ICER Chief Medical Officer David Rind told Reuters that prices have come down a ton in recent years, but high demand means payers are having a lot of problems with affordability of these drugs. ICER estimated the annual net US price for Novos semaglutide at US$6,830, down from US$13,618 in 2022, while Lillys tirzepatide came in at US$7,973 against a list price of about US$13,000
Patients who prioritize both tend to experience better skin quality throughout their weight loss journey
Retatrutide: Availability and Potential FDA Approval Retatrutide is close to changing how we treat obesity, with Phase 3 trials in full swing
For example, someone with severe B12 deficiency and neurological symptoms might need more frequent injections at first
Q: Can Retatrutide be studied with other metabolic compounds
Serious side effects such as gastroparesis were rare